Narges Azadbakht

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin-6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study.

Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin-6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 03, 2026

Non-melanoma skin cancer risk with Janus kinase inhibitors compared to interleukin-6 receptor inhibitors in rheumatoid arthritis: results from a national cohort study.

Non-melanoma skin cancer risk with Janus kinase inhibitors compared to interleukin-6 receptor inhibitors in rheumatoid arthritis: results from a national cohort study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 03, 2026

10-year multimorbidity patterns among people with and without rheumatic and musculoskeletal diseases: an observational cohort study using linked electronic health records from Wales, UK.

10-year multimorbidity patterns among people with and without rheumatic and musculoskeletal diseases: an observational cohort study using linked electronic health records from Wales, UK.

Journal: BMJ open

Published: June 21, 2024

Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA.

Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA.

Journal: Rheumatology (Oxford, England)

Published: May 10, 2024

A scoping review finds a growing trend in studies validating multimorbidity patterns and identifies five broad types of validation methods.

A scoping review finds a growing trend in studies validating multimorbidity patterns and identifies five broad types of validation methods.

Journal: Journal of clinical epidemiology

Published: May 17, 2023

Defining trajectories of response in patients with psoriasis treated with biologic therapies.

Defining trajectories of response in patients with psoriasis treated with biologic therapies.

Journal: The British journal of dermatology

Published: April 03, 2021

Application of SWATH mass spectrometry in the identification of circulating proteins does not predict future weight gain in early psychosis.

Application of SWATH mass spectrometry in the identification of circulating proteins does not predict future weight gain in early psychosis.

Journal: Clinical proteomics

Published: March 16, 2020

Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia.

Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia.

Journal: Journal of proteome research

Published: October 29, 2019

Identification of a Biomarker Panel for Early Detection of Lung Cancer Patients.

Identification of a Biomarker Panel for Early Detection of Lung Cancer Patients.

Journal: Journal of proteome research

Published: August 14, 2019

Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.

Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.

Journal: Leukemia

Published: December 20, 2017

Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.

Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.

Journal: Leukemia

Published: February 16, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026